Myotonic dystrophy type 1: role of CCG, CTC and CGG interruptions within DMPK alleles in the pathogenesis and molecular diagnosis
- 19 December 2016
- journal article
- review article
- Published by Wiley in Clinical Genetics
- Vol. 92 (4) , 355-364
Abstract
Myotonic dystrophy type 1 (DM1) is a multisystem neuromuscular disease caused by a CTG triplet expansion in the 3′‐untranslated region (3′‐UTR) of DMPK gene. This CTG array is usually uninterrupted in both healthy and DM1 patients, but recent studies identified pathological variant expansions containing unstable CCG, CTC and CGG interruptions with a prevalence of 3–5% of cases. In this review, we will describe the clinical, molecular and genetic issues related to the occurrence of variant expansions associated with DM1. Indeed, the identification of these complex DMPK alleles leads to practical consequences in DM1 genetic counseling and testing, because these exams can give false negative results. Moreover, DM1 patients carrying interrupted alleles can manifest either additional atypical neurological symptoms or, conversely, mild, late‐onset forms. Therefore, the prognosis of the disease in these patients is difficult to determine because of the great uncertainty about the genotype–phenotype correlations. We will discuss the putative effects of the variant DM1 alleles on the pathogenic disease mechanisms, including mitotic and meiotic repeats instability and splicing alteration typical of DM1 tissues. Interruptions within the DMPK expanded alleles could also interfere with the chromatin structure, the transcriptional activity of the DM1 locus and the interaction with RNA CUG‐binding proteins.Keywords
Funding Information
- Italian Ministry of Scientific Research (D1-2015)
This publication has 71 references indexed in Scilit:
- Next generation sequencing for molecular diagnosis of neurological disorders using ataxias as a modelBrain, 2013
- MBNL142 and MBNL143 gene isoforms, overexpressed in DM1-patient muscle, encode for nuclear proteins interacting with Src family kinasesCell Death & Disease, 2013
- Molecular Genetics and Genetic Testing in Myotonic Dystrophy Type 1BioMed Research International, 2013
- Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2European Journal of Human Genetics, 2012
- A complex phenotype of peripheral neuropathy, myopathy, hoarseness, and hearing loss is linked to an autosomal dominant mutation in MYH14Human Mutation, 2011
- Expanded CTG repeat demarcates a boundary for abnormal CpG methylation in myotonic dystrophy patient tissuesHuman Molecular Genetics, 2010
- Methylation of the CpG sites in the myotonic dystrophy locus does not correlate with CTG expansion size or with the congenital form of the diseaseJournal of Medical Genetics, 2010
- Overexpression of microRNA-206 in the skeletal muscle from myotonic dystrophy type 1 patientsJournal of Translational Medicine, 2010
- MBNL binds similar RNA structures in the CUG repeats of myotonic dystrophy and its pre-mRNA substrate cardiac troponin TRNA, 2007
- Recombinant Human DNA (Cytosine-5) MethyltransferaseJournal of Biological Chemistry, 1999